2024 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
811 M |
-67.4 % |
2023 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
2.5 B |
268.3 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
- |
676 M |
8.2 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
676 M |
8.2 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
625 M |
-5.9 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
- |
625 M |
-5.9 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
625 M |
-5.9 % |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
664 M |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
664 M |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
664 M |
- |
2019 |
Takeda Pharmaceutical Co - ADR
|
Director and Chief Financial Officer |
- |
- |